3BUG
BACE-1 complexed with compound 3
Summary for 3BUG
Entry DOI | 10.2210/pdb3bug/pdb |
Related | 3BRA 3BUF 3BUH |
Descriptor | BETA-SECRETASE 1, 4-(2-aminoethyl)-2-ethylphenol (3 entities in total) |
Functional Keywords | alzheimer's disease, aspartic protease, beta-secretase, memapsin 2, fragment screen, alternative splicing, aspartyl protease, glycoprotein, hydrolase, membrane, transmembrane, zymogen |
Biological source | Homo sapiens (human) |
Cellular location | Membrane; Single-pass type I membrane protein: P56817 |
Total number of polymer chains | 1 |
Total formula weight | 45719.24 |
Authors | Kuglstatter, A.,Hennig, M. (deposition date: 2008-01-02, release date: 2008-03-11, Last modification date: 2024-10-30) |
Primary citation | Kuglstatter, A.,Stahl, M.,Peters, J.U.,Huber, W.,Stihle, M.,Schlatter, D.,Benz, J.,Ruf, A.,Roth, D.,Enderle, T.,Hennig, M. Tyramine fragment binding to BACE-1 Bioorg.Med.Chem.Lett., 18:1304-1307, 2008 Cited by PubMed Abstract: Fragment screening revealed that tyramine binds to the active site of the Alzheimer's disease drug target BACE-1. Hit expansion by selection of compounds from the Roche compound library identified tyramine derivatives with improved binding affinities as monitored by surface plasmon resonance. X-ray structures show that the amine of the tyramine fragment hydrogen-bonds to the catalytic water molecule. Structure-guided ligand design led to the synthesis of further low molecular weight compounds that are starting points for chemical leads. PubMed: 18226904DOI: 10.1016/j.bmcl.2008.01.032 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.5 Å) |
Structure validation
Download full validation report